NANOBIOTIX
LIVE

Serial Number

79315504

Owner

NANOBIOTIX

Attorney

James R Menker

Filing Date

Mar 31, 2021

Add to watchlist:

No watchlists yet
View on USPTO

NANOBIOTIX Trademark

Serial Number: 79315504 • Registration: 6841426

NANOBIOTIX is a trademark filed by NANOBIOTIX on March 31, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

NANOBIOTIX (30 trademarks)

60 rue de Wattignies

Entity Type: 99

Trademark Details

Filing Date

March 31, 2021

Registration Date

September 13, 2022

Published for Opposition

June 28, 2022

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 9, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 15, 2022 FICS
FINAL DISPOSITION PROCESSED
Dec 15, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 13, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 20, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 15, 2022 TROA
REFUSAL PROCESSED BY IB
Jan 10, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 21, 2021 RFCS
REFUSAL PROCESSED BY MPU
Dec 21, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 19, 2021 RFCR
NON-FINAL ACTION WRITTEN
Nov 18, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 15, 2021 DOCK
LIMITATION FROM THE IB EXAMINED AND ENTERED
Oct 5, 2021 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Sep 19, 2021 LIMG
NEW REPRESENTATIVE AT IB RECEIVED
Sep 18, 2021 NREP
APPLICATION FILING RECEIPT MAILED
Jul 24, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 15, 2021 REPR